Search Results
Search results for "Marc Caron"
Results found for "Marc Caron"
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial "MONTREAL (CANADA) – March 15, 2022 – Inversago Pharma Inc.
- đź“° GPCR Weekly News, January 1 to 7, 2024
| SLAS2024 International Conference and Exhibition February 11 - 14, 2024 | 2024 BPS Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance Strasbourg and Bordeaux, France, March 10, 2022 – Domain Therapeutics, a biopharmaceutical company specializing
- đź“° Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Our Chief Matchmaker, Mark Schmeizl, is here to assist you. | SLAS2024 International Conference and Exhibition February 11 - 14, 2023 | 2024 BPS Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April
- đź“° GPCR Weekly News, November 20 to 26, 2023
Let Mark Schmeizl, our Chief Matchmaker help. Contact him by filling out this form. SLAS2024 International Conference and Exhibition NEW February 11 - 14, 2023 | 2024 BPS Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs - Contact Mark
- đź“° GPCR Weekly News, January 23 to 29, 2023
SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (February 20 - March 3, 2023). GEM2023. (March 14-17, 2023).
- đź“° GPCR Weekly News, November 13 to 19, 2023
2024 | 23rd Annual PEP Talk February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April
- đź“° GPCR Weekly News, January 16 to 22, 2023
SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School (February 20 - March 3, 2023). GEM2023. (March 14-17, 2023).
- đź“° GPCR Weekly News - January 9 to 15, 2023
SLAS2023 International Conference and Exhibition (February 25 - March 1). (February 20 - March 3, 2023). GEM2023. (March 14-17, 2023). 8th and final ERNEST Meeting in Crete.
- đź“° GPCR Weekly News, December 18 to 31, 2023
| SLAS2024 International Conference and Exhibition February 11 - 14, 2024 | 2024 BPS Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April
- Structural landscape of the Chemokine Receptor system
All CKRs studied show the canonical active conformation, except CX3CR1 which displays a significantly As a result of the unique active conformation, the residues in the microswitch network show non-canonical The Non-canonical Toggle Switch 6.48 - CCR6 as a model CKR The structure of CCR6 bound to CCL20 reveals the "toggle switch" position 6.48 and the disruption of a hydrogen-bond network surrounding this non-canonical
- Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment ...
March 2022 Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment Neuropathic Pain "— Confo’s first drug candidate moves into clinical development — Ghent, Belgium – March
- đź“° GPCR Weekly News, October 2 to 8, 2023
ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition
- Newly launched antibody libraries put hard-to-drug targets within reach
Aaron Sato, Chief Scientific Officer at Twist Bioscience, elaborates.
- ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
March 2022 "February 17, 2022 08:00 AM Eastern Standard Time SAN FRANCISCO & SHANGHAI- ShouTi Inc., a
- đź“° GPCR Weekly News, October 9 to 15, 2023
ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
previous studies determining the 5-HT2AR structure, its molecular interactions with various ligands and canonical Slosky LM, Caron MG, Barak LS. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
- GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...
highly-conserved GPCR-autoproteolysis-inducing (GAIN) domain, the latter of which is located immediately before a canonical
- Latrophilin-1 drives neuron morphogenesis and shapes chemo- and mechanosensation-dependent ...
7TM-independent functions of Latrophilins are essential for neuronal physiology, possibly complementing canonical
- Exscientia welcomes Richard J. Law, as their new Chief Business Officer
March 2022 "Congratulations to Richard J. Law, our newly named Chief Business Officer.
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! âť„ Dec 2 - 8, 2024
February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28, 2025 | 10th German Pharm-Tox Summit April 1 - 5,
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
March 2022 ERNEST has established an Emergency Fund for Ukrainian researchers.
- đź“° GPCR Weekly News
GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. 2nd ERNEST Training School – February 20th to March GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete.
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group "CHESTERBROOK, Pa., March
- đź“° GPCR Weekly News, October 16 to 22, 2023
You can find more information about them on the Live Talks page and mark your calendar HERE. ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition
- How Schild Analysis Protects Your Conclusions in GPCR Research
Use the four canonical criteria to distinguish genuine orthosteric antagonism from apparent shifts that
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
GPCR Events You can begin organizing and marking a few dates in 2025 . February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28, 2025 | 10th German Pharm-Tox Summit April 1 - 5,
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Mark your calendar, it's happening September 22-25, 2025. Aaron McGrath from Takeda  🎥 Interview with Kris Borzilleri & Alison Heick Varghese from Pfizer 🎥 Let’s move GPCR drug discovery forward — together. 🚨 Mark your calendar for the GPCR Happy Hour Join
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Must-read publications: Â A structural modeling study revealing non-canonical mechanisms of chemokine-driven
- đź“° GPCR Weekly News, September 25 to October 1, 2023
ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition






